|
|
|
Taglich's Company Profile
for: |
www.kefir.com |
Lifeway Foods, Inc. |
Symbol:
LWAY
Analyst:
Howard Halpern
Taglich Rating:
Speculative Buy
Price Target:
$13.65
Time Horizon:
12 Months
Rating Established:
April 19. 2007
Price When Established:
$9.24
Most Recent Report:
April 14, 2008
Price When Issued:
$12.32
|
|
|
Most Recent Update |
|
Updated
Research Report (Dated April 14, 2008) |
|
What's New |
|
New information will be posted soon... |
|
Company Description |
|
Lifeway Foods, Inc., (LWAY) based in Morton Grove, Illinois is a manufacturer of cultured, probiotic and functional food products in the health food industry, and is America's leading supplier of the cultured dairy product known as kefir. Their products are sold to health conscious consumers through health food stores and to the mass-market consumers through supermarkets. |
|
Taglich Research Reports |
|
Updated
Earnings Note (Dated April 1, 2008)
Updated Research Note (Dated February 27, 2008)
Updated
Research Report (Dated December 10, 2007)
Updated
Earnings Note (Dated November 15, 2007)
Updated
Research Report (Dated September 5, 2007)
Updated
Research Note (Dated July 9, 2007)
Updated
Research Report (Dated June 11, 2007)
Updated
Research Report (Dated April 19, 2007)
Updated
Research Report (Dated December 14, 2006)
Updated
Research Report (Dated September 18, 2006)
Updated
Research Report (Dated May 25, 2006)
Updated
Research Report (Dated April 27, 2006)
Updated
Research Report (Dated December 5, 2005)
Updated Research Report (Dated August 29, 2005)
Updated
Research Report (Dated July 14, 2005)
Updated
Research Report (Dated May 27, 2005)
Updated
Research Report (Dated April 20, 2005)
Updated
Research Report (Dated December 7, 2004)
Updated
Research Report (Dated September 24, 2004)
Updated
Research Report (Dated June 8, 2004)
Updated
Research Report (Dated April 14, 2004)
Updated
Research Report (Dated December 1, 2003)
Updated
Research Report (Dated September 12, 2003)
Updated
Research Report (Dated June 11, 2003)
Updated Research Report (Dated April 3, 2003)
Updated
Research Report (Dated November 25, 2002)
Updated
Research Report (Dated August 21, 2002)
Updated
Research Report (Dated May 24, 2002)
Updated
Research Report (Dated March 12, 2002)
Updated
Research Report (Dated November 26, 2001)
Updated
Research Report (Dated August 23, 2001)
Updated
Research Report (Dated June, 12 2001)
Updated
Research Report (Dated April 30, 2001)
Initial
Research Report (Dated December 5, 2000)
All Research Reports are in Adobe Acrobat format.
(for the latest Adobe Acrobat reader click
here)
The information and statistical data
contained herein have been obtained from sources, which we believe to be
reliable but in no way are warranted by us as to accuracy or
completeness. We do not undertake to advise you as to changes in figures
or our views. This is not a solicitation of any order to buy or sell.
Taglich Brothers, Inc. is fully disclosed with its clearing firm,
Pershing, LLC, is not a market maker and does not sell to or buy from
customers on a principal basis. The above statements are the opinion of
Taglich Brothers, Inc. and are not a guarantee that the target price for
the stock will be met or that predicted business results for the company
will occur. There may be instances when fundamental, technical and
quantitative opinions contained in the reports are not in concert. We,
our affiliates, any officer, director or stockholder or any member of
their families may from time to time purchase or sell any of the
above-mentioned or related securities. Analysts and members of the
Research Department are prohibited from buying or selling securities
issued by the companies that Taglich Brothers, Inc. has a research
relationship with, except if ownership of such securities was prior to
the start of such relationship, then an Analyst or member of the
Research Department may sell such securities after obtaining expressed
written permission from the Director of Research. All research issued by
Taglich Brothers, Inc. is based on public information. Taglich Brothers,
Inc. does not currently have an Investment Banking relationship with the
company mentioned and was not a manager or co-manager of any offering
for the company within the last three years. Since December 2000, the
company pays a monthly monetary fee of $1,500 (USD) to Taglich Brothers,
Inc. for the creation and dissemination of research reports. For further
information and Taglich Brothers, Inc. ownership data please refer to
each individual report. |
|
Send this Page to a friend |
|
To send this page to a friend, just fill out the form below and press
the "send it" button!
|
|
|
Taglich Covered Companies |
AeroCentury Corp.
Anglo Swiss Resources, Inc.
Avensys Corporation
BioForce Nanosci. Holdings, Inc.
Caneum Inc.
Cardium Therapeutics, Inc.
China 3C Group
Command Security Corp.
CTI Industries Corp
Derma Sciences, Inc.
DRI Corporation
EnerLume Energy Mgt. Corp.
EP MedSystems, Inc.
Exeter Resource Corp.
GammaCan International, Inc.
Hartmarx Corporation
Helios & Matheson North America
INX, Inc.
Leading Brands, Inc.
Life Partners Holdings, Inc.
Lifeway Foods, Inc.
Littlefield Corporation
Manchester, Inc.
MFIC Corporation
Orchids Paper Products
Park City Group, Inc.
Pressure BioSciences, Inc.
QPC Lasers, Inc.
Radiant Logistics, Inc.
Reed's Inc.
Salon Media Group, Inc.
Simulations Plus, Inc.
TranSwitch Corporation
Triton Dist. Sys., Inc.
UFP Technologies, Inc.
US 1 Industries, Inc.
Wave Systems Corp.
Williams Controls, Inc.
|
|
